|4Mar 15, 4:28 PM ET

PRGX GLOBAL, INC. 4

4 · PRGX GLOBAL, INC. · Filed Mar 15, 2017

Insider Transaction Report

Form 4
Period: 2017-03-13
Cochrane Michael
SVP, Global Client Operations
Transactions
  • Sale

    Common Stock

    2017-03-13$6.22/sh8,333$51,82182,125 total
  • Exercise/Conversion

    Stock Option

    2017-03-138,3330 total
    Exercise: $3.96Exp: 2017-06-22Common Stock (8,333 underlying)
  • Exercise/Conversion

    Common Stock

    2017-03-13$3.96/sh+8,333$32,99990,458 total
Footnotes (3)
  • [F1]Includes 13,334 shares that vest on June 27, 2017.
  • [F2]The sale price indicated is a weighted average selling price. The corresponding shares were sold in multiple transactions at prices ranging from $6.20 to $6.25, inclusive. The reporting person undertakes to provide to PRGX Global, Inc., any security holder of PRGX Global, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.
  • [F3]The option exercises reported on this Form 4 represents an exercise of the option grant made on June 23, 2010, which vested 1/3 on June 23, 2011, 1/3 on June 23, 2012, and 1/3 on June 23, 2013.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION